DocDollars

Abbott Laboratories

IL · United States · Reporting entity ID 100000010680

Total reported 2019–2025
$714.9M
#22 of 2,960 reporting companies — 0.9% of all reported industry payments
$243.8M in general payments across 1,695,759 records, plus $471.1M in research funding across 90,013 records.

How it breaks down

General payments $243,782,933
Research funding $471,087,936

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Abbott Laboratories reported $714.9M to US doctors and teaching hospitals from 2019 to 2025, ranking #22 of 2,960 reporting companies. 66% of that was research funding and 34% general payments such as consulting, speaking, food and travel. 1,695,759 general payment records and 90,013 research records were filed.

Common questions about Abbott Laboratories

How much has Abbott Laboratories paid US doctors?

Abbott Laboratories reported $714,870,869 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $243,782,933 in general payments, $471,087,936 in research funding.

How does Abbott Laboratories rank among drug and device companies?

It ranks #22 of 2,960 reporting entities by total reported value, about 0.9% of all industry payments in the dataset.

Does a payment from Abbott Laboratories mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.